Serum deglycosylation coupled with label-free quantification was applied to biomarker screening for lung cancer and led to the identification of unique biomarker candidates including the fragmentation state of complement C3, complement component C9 peptide with novel O-linked carbohydrate and Kininogen-1 peptide with C-terminal Phe[24]. Here, C9 is linked to lung carcinoma.